Form 8-K - Current report:
SEC Accession No. 0001493152-21-006952
Filing Date
2021-03-26
Accepted
2021-03-26 17:22:48
Documents
12
Period of Report
2021-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32685
  Complete submission text file 0001493152-21-006952.txt   204912

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lctx-20210323.xsd EX-101.SCH 2766
3 XBRL LABEL FILE lctx-20210323_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE lctx-20210323_pre.xml EX-101.PRE 22717
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3618
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 21778592
SIC: 2836 Biological Products, (No Diagnostic Substances)